IDEAYA Biosciences Hits Day High with 11.28% Surge in Stock Price

IDEAYA Biosciences, Inc. experienced a significant surge in its stock price, gaining 11.28% on June 8, 2026, and reaching an intraday high of USD 31.63. This performance stands out against the S&P 500, which saw a modest increase of 0.3% on the same day. Over the past week, IDEAYA has shown an impressive 8.78% increase, while the S&P 500 declined by 2.56%. In terms of longer-term performance, IDEAYA has delivered a 44.87% return over the past year, significantly outperforming the S&P 500's 23.42%. However, year-to-date, the stock is down 8.94%, contrasting with the S&P 500's gain of 8.18%. The company has reported positive results for the last three consecutive quarters, with net sales for the half-year reaching USD 17.44 million, reflecting a remarkable growth of 149.09%. Despite the stock's recent volatility, it maintains a high institutional ownership of 100%, indicating strong confidence from institutional investors. IDEAYA operates within the Pharmaceuticals & Biotechnology sector and has a market capitalization of USD 2,675 million.